Headline News about Cybin Inc![]() ![]()
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]()
Cybin Inc. Receives Schedule I Manufacturing License from DEA
November 04, 2021
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Via Benzinga
Exposures
Product Safety
![]() Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma
October 19, 2021
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|